Bioresorbable Stent (BRS) Device Market was valued at USD 0.95 Billion in 2022 and is projected to reach USD 2.67 Billion by 2030, growing at a CAGR of 15.20% from 2024 to 2030.
The Bioresorbable Stent (BRS) Device Market is a rapidly growing sector within the medical device industry, particularly in the field of cardiovascular interventions. These stents, designed to be absorbed by the body over time, offer an alternative to traditional metallic stents, which remain in the body indefinitely. BRS devices are gaining attention due to their potential to reduce long-term complications associated with permanent implants, such as restenosis and thrombosis. The market for BRS devices is evolving, driven by advancements in materials science, such as the use of biodegradable polymers and metals like magnesium and poly-L-lactic acid. The application of BRS devices extends to treating coronary and peripheral artery diseases, two major conditions affecting global populations. These diseases are leading causes of morbidity and mortality, creating significant demand for innovative treatment options like bioresorbable stents.
Download Full PDF Sample Copy of Global Bioresorbable Stent (BRS) Device Report @ https://www.verifiedmarketreports.com/download-sample/?rid=774226&utm_source=Google_site&utm_medium=230
The Bioresorbable Stent (BRS) Device Market is categorized by its key application areas, particularly in treating Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD). These two segments constitute the core focus of the BRS market, with distinct challenges and opportunities associated with each condition.
Coronary Artery Disease is the most common form of heart disease, caused by the buildup of plaque in the coronary arteries, which can lead to restricted blood flow to the heart. The application of BRS devices in CAD treatment aims to restore this flow by temporarily supporting the artery after an angioplasty procedure. The bioresorbable stent serves as a temporary scaffold that dissolves over time, reducing the risk of long-term complications such as restenosis, which occurs when the artery narrows again. As CAD remains a leading cause of death worldwide, the use of BRS devices offers the potential to improve patient outcomes by providing a solution that avoids the long-term risks associated with permanent metallic stents.
The growing demand for minimally invasive procedures in CAD treatment, coupled with advancements in stent technology, has significantly boosted the market for BRS in coronary applications. BRS devices, particularly those made from resorbable materials like magnesium, promise to deliver not only short-term efficacy but also long-term health benefits. These devices reduce the need for repeated surgeries, which is a key factor in the growing preference for bioresorbable options over traditional stenting methods. The potential to eliminate the need for a permanent implant is driving innovation and increasing the market penetration of BRS devices for coronary artery treatments.
Peripheral Artery Disease refers to the narrowing or blockage of the peripheral arteries, commonly in the legs, due to plaque buildup, which can impair blood circulation and lead to symptoms like pain, numbness, and even gangrene in severe cases. BRS devices are increasingly being considered for the treatment of PAD, especially as the demand for more effective and less invasive solutions grows. The application of BRS in PAD allows for temporary vessel support during the healing phase, after which the stent is resorbed by the body, eliminating the long-term risks associated with permanent foreign materials. The use of BRS devices in PAD procedures is particularly advantageous as it minimizes the need for long-term monitoring and secondary interventions that are common with traditional metallic stents.
The market for BRS devices in PAD applications is expanding due to the increasing prevalence of this disease, especially among aging populations and individuals with risk factors such as diabetes, hypertension, and smoking. PAD has significant clinical implications, and the need for better treatment options to improve quality of life and prevent complications is urgent. The resorbable nature of these devices presents an opportunity to enhance patient outcomes, offering a less invasive and more sustainable solution for arterial reconstruction. This segment is expected to continue growing as the technology evolves, offering new possibilities for treating PAD with bioresorbable materials that adapt to the healing process and minimize adverse effects.
One of the primary trends shaping the Bioresorbable Stent (BRS) Device Market is the continuous improvement in the materials used for stent fabrication. The focus on biocompatible, biodegradable materials such as poly-L-lactic acid (PLLA) and magnesium alloys is driving the development of more effective and safer BRS devices. These materials are designed to provide temporary arterial support, offering improved biocompatibility and reduced risk of complications such as inflammation or thrombosis, which are common with traditional metal stents. Advances in the manufacturing process, including precision engineering and drug-eluting coatings, have also enhanced the performance of BRS devices, making them more viable for a wider range of patients with CAD and PAD.
Another key trend is the increasing adoption of minimally invasive surgical techniques. The demand for BRS devices is growing in tandem with the rise of percutaneous interventions, which are less invasive and offer faster recovery times compared to traditional open surgeries. As the technology behind BRS devices continues to evolve, there is a growing emphasis on improving the stent's mechanical properties, such as flexibility and radial strength, to ensure successful long-term outcomes. These innovations are likely to drive broader acceptance and utilization of BRS devices in clinical practice, particularly in regions with advanced healthcare infrastructure.
The Bioresorbable Stent (BRS) Device Market presents significant growth opportunities driven by several factors. One of the primary opportunities is the expanding patient base for both CAD and PAD treatments. As the global population ages and the prevalence of risk factors like hypertension and diabetes rises, the demand for innovative treatment options such as BRS devices is expected to increase. BRS devices present a unique opportunity to address the limitations of traditional stents, offering benefits such as reduced long-term risks and improved patient quality of life.
Another opportunity lies in the ongoing advancements in stent technology, which continue to improve the safety and effectiveness of BRS devices. Research and development into new bioresorbable materials and drug-eluting technologies are likely to open up new possibilities for BRS device applications, particularly in complex clinical scenarios where traditional stents may not be as effective. Furthermore, the growing emphasis on personalized medicine, which tailors treatments to individual patient needs, offers an opportunity for BRS devices to be adapted to a wider range of patients based on their unique anatomical and physiological characteristics.
What is a Bioresorbable Stent (BRS)?
A Bioresorbable Stent (BRS) is a type of stent made from biodegradable materials that temporarily supports an artery after a procedure and then dissolves over time.
What is the main advantage of BRS devices over traditional stents?
The main advantage is that BRS devices dissolve over time, reducing the risk of long-term complications like restenosis and thrombosis, unlike permanent metallic stents.
Are BRS devices more effective than traditional metallic stents?
BRS devices have shown promise in reducing long-term complications, but their effectiveness may depend on individual patient factors and specific clinical scenarios.
What conditions are treated with BRS devices?
BRS devices are primarily used to treat Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD), where arterial support is needed.
How long do BRS devices take to dissolve in the body?
The time for BRS devices to dissolve can vary, but typically it takes several months to a few years for the stent to be fully resorbed.
Are BRS devices suitable for all patients?
While BRS devices offer many benefits, their suitability depends on the patient's specific condition and anatomical characteristics, and should be assessed by a healthcare professional.
What materials are commonly used in BRS devices?
Common materials used in BRS devices include poly-L-lactic acid (PLLA), magnesium alloys, and other biodegradable polymers.
What are the risks associated with BRS devices?
Risks may include stent thrombosis, restenosis, or delayed resorption in some cases, though these risks are generally lower than with permanent metallic stents.
How are BRS devices deployed in the body?
BRS devices are deployed using minimally invasive techniques such as angioplasty or percutaneous coronary interventions, similar to traditional stent procedures.
What is the future outlook for the BRS device market?
The BRS device market is expected to grow significantly as technology improves, offering better safety, efficacy, and patient outcomes, especially in treating CAD and PAD.```
Download Full PDF Sample Copy of Global Bioresorbable Stent (BRS) Device Report @ https://www.verifiedmarketreports.com/download-sample/?rid=774226&utm_source=Google_site&utm_medium=230
Lepu Medical
Biotronik
Abbott
REVA
MeKo
Boston Scientific Corporation
Arterius Limited
Kyoto Medical Planning Co. Ltd
Terumo Corporation
Elixir Medical Corporation
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase Of This Report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=774226&utm_source=Google_site&utm_medium=230
Growing demand for below applications around the world has had a direct impact on the growth of the Global Bioresorbable Stent (BRS) Device Market
Coronary Artery Disease
Peripheral Artery Disease
Based on Types the Market is categorized into Below types that held the largest Bioresorbable Stent (BRS) Device market share In 2023.
Polymer-based Bioabsorbable Stents
Metal-based Bioabsorbable Stents
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
1. Introduction of the Global Bioresorbable Stent (BRS) Device Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Bioresorbable Stent (BRS) Device Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Bioresorbable Stent (BRS) Device Market, By Type
6. Global Bioresorbable Stent (BRS) Device Market, By Application
7. Global Bioresorbable Stent (BRS) Device Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Bioresorbable Stent (BRS) Device Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/